1-3 of 3
Rosemary Hoyt
Close
Sort by
Journal Articles

Complete Remission on 18F-FDG-PET Prior to Autologous Stem Cell Transplantation Predicts Superior Event Free Survival of Patients with Relapsed or Refractory Hodgkin Lymphoma.

Stefan Peinert, Rosemary Hoyt, Jeffrey Szer, John F. Seymour, H. Miles Prince, Andrew W Roberts, Luigi Rigacci, Andrew Grigg, David S. Ritchie
Journal: Blood
Blood (2008) 112 (11): 2188.
https://doi.org/10.1182/blood.V112.11.2188.2188
Published: 2008
Journal Articles

Low Predictive Value of Functional Imaging with 18 FDG-PET or Gallium Scanning in Relapsed or Refractory Hodgkin Lymphoma Prior to Autologous Stem Cell Transplantation.

Stefan Peinert, MD, Rosemary Hoyt, MD, Jeff Szer, MD, Andrew Roberts, MD, Andrew Grigg, MD, H. Miles Prince, MD, Luigi Rigacci, MD, John F. Seymour, MD, David S. Ritchie, MD
Journal: Blood
Blood (2007) 110 (11): 5127.
https://doi.org/10.1182/blood.V110.11.5127.5127
Published: 2007
Journal Articles

Improved Relapse Free Survival Is Predicted by a Negative Pre-Transplant FDG-PET Scan Following Salvage Chemotherapy for Relapsed Diffuse Large B Cell Lymphoma (DLBCL) Treated with Autologous Stem Cell Transplantation.

Michael J. Dickinson, MBBS, Rosemary Hoyt, BN, Andrew Roberts, MBBS PhD, Andrew Grigg, MBBS, John Francis Seymour, MBBS PhD, Jeff Szer, MBBS BSc BMedSci, H. Miles Prince, MBBS(Hons)MD, David Ritchie, MBChB PhD
Journal: Blood
Blood (2007) 110 (11): 5115.
https://doi.org/10.1182/blood.V110.11.5115.5115
Published: 2007